Two ligands for TIGIT, CD155 (PVR) and CD112 (PVRL2, nectin-2), are expressed on APCs, T lymphocytes, and on non-hematopoietic cell types including tumor cells [32,49]. This evidence concerns the gene NECTIN2 and neoplasm.